Pharvaris N.V. Files 6-K Report
Ticker: PHVS · Form: 6-K · Filed: 2024-11-13T00:00:00.000Z
Sentiment: neutral
Topics: 6-K, foreign-issuer, disclosure
Related Tickers: PHVS
TL;DR
Pharvaris N.V. (PHVS) filed a 6-K, standard foreign issuer report.
AI Summary
Pharvaris N.V. filed a Form 6-K on November 13, 2024, to report information for the month of November 2024. The company, previously known as Pharvaris, B.V., is incorporated in the Netherlands and operates in the pharmaceutical preparations sector. This filing is made under the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates and disclosures for Pharvaris N.V. as a foreign private issuer, which is important for investors tracking the company's compliance and reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- Pharvaris N.V. (company) — Registrant
- Pharvaris, B.V. (company) — Former company name
- 20241113 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of November 2024.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001830487.
What is the company's Standard Industrial Classification (SIC) code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
When did the company change its name from Pharvaris, B.V.?
The company changed its name from Pharvaris, B.V. on October 29, 2020.
Does Pharvaris N.V. file its annual reports under Form 20-F or Form 40-F?
Pharvaris N.V. files its annual reports under cover of Form 20-F.
From the Filing
0000950170-24-126327.txt : 20241113 0000950170-24-126327.hdr.sgml : 20241113 20241113161204 ACCESSION NUMBER: 0000950170-24-126327 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20241113 FILED AS OF DATE: 20241113 DATE AS OF CHANGE: 20241113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 241454315 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 6-k_q3_24.htm 6-K 6-K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-40010     Pharvaris N.V.   (Translation of registrant’s name into English)   Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐ Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.           PHARVARIS N.V.   On November 13, 2024, Pharvaris N.V. issued a press release reporting financial results and other business updates for the three and nine months ended September 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act. Exhibits 99.2 and 99.3 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Number 333-273757, 333-277705 and 333-278650) and Form S-8 (Registration Number 333-252897) of Pharvaris N.V. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.           EXHIBIT INDEX   Exhibit No.   Description 99.1   Press Release, dated